Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Mono Pharmacare Limited (NSE: MONOPHARMA), ISIN INE0OIP01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MONOPHARMA last traded at ₹8.20 (-0.61%), with a 52-week range of ₹7.50 to ₹24.25 (as of 23 Sep 2026).
Shareholding as of Mar 2026: promoters 56.72%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 18/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.